Stimulated peripheral production of interferon-gamma is related to fatigue and depression in multiple sclerosis

Clinical Neurology and Neurosurgery

Volumn 114, Issue 8, 2012, Pages 1153-1158

  Pokryszko Dragan, A ^a   Frydecka, I ^a,b   Kosmaczewska, A ^b   Ciszak, L ^b   Bilinska M ^a   Gruszka, E ^a   Podemski, R ^a   Frydecka, D ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Depression; Fatigue; Interferon gamma; Multiple sclerosis

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FEMALE; FLOW CYTOMETRY; HUMAN; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; MALE; MULTIPLE SCLEROSIS; PROTEIN EXPRESSION; RECURRENCE RISK;

ADULT; DEPRESSION; DISABILITY EVALUATION; DISEASE PROGRESSION; FATIGUE; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; QUESTIONNAIRES; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84865491972     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2012.02.048     Document Type: Article

References (44)

1. R. Bakshi Fatigue associated with multiple sclerosis: diagnosis, impact and management Mult Scler 9 2003 219 227
2. G. Comi, L. Leocani, P. Rossi, and B. Colombo Physiopathology and treatment of fatigue in multiple sclerosis J Neurol 248 2001 174 179
3. J.P. Konsman, P. Panet, and R. Dantzer Cytokine-induced sickness behaviour: mechanism and implications Trends Neurosci 25 2002 154 159
4. R. Patarca Cytokines and chronic fatigue syndrome Ann NY Acad Sci 933 2001 185 200
5. N.G. Klimas, F.R. Salvato, R. Morgan, and M.A. Fletcher Immunological abnormalities in chronic fatigue syndrome J Clin Microbiol 28 1990 1403 1410
6. L. Lorusso, S.V. Mikhaylova, E. Capelli, D. Ferrari, G.K. Ngonga, and G. Ricevuti Immunological aspects of chronic fatigue syndrome Autoimm Rev 8 2009 287 291
7. J.B. Prins, W.M. Van der Meer, and G. Bleijenberg Chronic fatigue syndrome Lancet 367 2006 346 355
8. M. Maes, F.N. Twisk, M. Kubera, and K. Ringel Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin J Affect Disord October 2011 [Epub ahead of print]
9. J.R. Kerr, F. Barah, D.L. Mattey, I. Laing, S.J. Hopkins, and I.V. Hutchinson Circulating tumour necrosis factor-a and interferon-c are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue J Gen Virol 82 2001 3011 3019
10. R. Bellmann-Weiler, K. Schroecksnadel, C. Holzer, C. Larcher, D. Fuchs, and G. Weiss IFN-gamma mediated pathways in patients with fatigue and chronic active Epstein Barr virus-infection J Aff Disord 108 2008 171 176
11. C. Heesen, L. Nawrath, C. Reich, N. Bauer, K.-H. Schulz, and S.M. Gold Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry 77 2006 34 39
12. C. Heesen, G. Koehler, R. Gross, W. Tessmer, K.H. Schulz, and S.M. Gold Altered cytokine responses to cognitive stress in multiple sclerosis patients with fatigue Mult Scler 11 2005 51 57
13. P. Flachenecker, I. Bihler, F. Weber, M. Gottschalk, K.V. Toyka, and P. Rieckmann Cytokine mRNA expression in patients with multiple sclerosis and fatigue Mult Scler 10 2004 165 169
14. G. Giovannoni, A.J. Thompson, D.H. Miller, and E.J. Thompson Fatigue is not associated with raised inflammatory markers in multiple sclerosis Neurology 57 2001 676 681
15. J. Iriarte, M. Subira, and P. De Castro Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors Mult Scler 6 2000 124 130
16. R.A. Rudick, and B.P. Barna Serum interleukin 2 and soluble interleukin 2 receptor in patients with multiple sclerosis who are experiencing severe fatigue Arch Neurol 47 1990 254 255
17. K. Bertolone, P.K. Coyle, L.B. Krupp, and C.A. Doscher Cytokine correlates of fatigue in multiple sclerosis Neurology 43 1993 A356
18. M. Maes An intriguing and hitherto unexplained co-occurrence: depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways Prog Neuropsychopharmacol Biol Psychiatry 35 2011 784 794
19. C.H. Polman, S.C. Reingold, G. Edan, M. Filippi, H.P. Hartung, and L. Kappos Diagnostic criteria for multiple sclerosis: 2005 revision to the "McDonald Criteria" Ann Neurol 58 2005 840 846
20. L.B. Krupp, N.G. Larocca, J. Muir-Nash, and A.D. Steinberg The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus Arch Neurol 46 1989 1121 1123
21. R.J. Mills, C.A. Young, R.S. Nicholas, J.F. Pallant, and A. Tennant Rasch analysis of the Fatigue Severity Scale in multiple sclerosis Mult Scler 15 2009 81 88
22. Multiple Sclerosis Council for Clinical Practice Guidelines: Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis, 1998.
23. R.J. Mills, C.A. Young, J.F. Pallant, and A. Tennant Rasch analysis of the Modified Fatigue Impact Scale in multiple sclerosis J Neurol Neurosurg Psychiatry 81 2010 1049 1051
24. J.M. Kurtzke Rating neurological impairment in multiple sclerosis: an expanded disability status scale Neurology 33 1983 1444 1452
25. R.H.S.R. Roxburgh, S.R. Seaman, T. Masterman, A.E. Hensiek, S.J. Sawcer, and S. Vukusic Multiple Sclerosis Severity Score. Using disability and disease duration to rate disease severity Neurology 64 2005 1144 1151
26. A.T. Beck, C.H. Ward, M. Medelson, J. Mock, and J. Erbaugh An inventory for measuring depression Arch Gen Psychiatry 4 1961 561 571
27. D.C. Mohr, D.E. Goodkin, W. Likosky, L. Beutler, N. Gatto, and M.K. Langan Identification of Beck Depression Inventory Items related to multiple sclerosis J Behav Med 20 1997 407 414
28. A. Lloyd, I. Hickie, C. Hickie, J. Dwyer, and D. Wakefield Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression Clin Exp Immunol 87 1992 76 79
29. A. Linde, B. Andersson, S.B. Svenson, H. Ahrne, M. Carlsson, and P. Forsberg Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome J Inf Dis 165 1992 994 1000
30. G. Cavadini, S. Petrzilka, P. Kohler, C. Jud, I. Tobler, and T. Birchler TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription Proc Natl Acad Sci USA 104 2007 12843 12848
31. A.K. Rasmussen, H. Nielsen, V. Andersen, T. Barington, K. Bendtzen, and M.B. Hansen Chronic fatigue syndrome - a controlled cross-sectional study J Rheumat 21 1994 1527 1531
32. O. Yaldizli, M. Kumar, S. Vago, E. Kreuzfelder, V. Limmroth, and N. Putzki Fatigue is not associated with impaired function of regulatory T cells in untreated patients with multiple sclerosis Eur Neurol 62 2009 321 326
33. A. Kosmaczewska, M. Bilinska, L. Ciszak, L. Noga, E. Pawlak, and A. Szteblich Different patterns of activation markers expression and CD4+ T-cell responses to ex vivo stimulation in patients with clinically quiescent multiple sclerosis (MS) J Neuroimmunol 189 2007 137 146
34. A. Sluzewska, J. Rybakowski, E. Bosmans, M. Sobieska, R. Berghmans, and M. Maes Indicators of immune activation in major depression Psychiatry Res 64 1996 161 167
35. A.H. Miller, V. Maletic, and C.L. Raison Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression Biol Psychiatr 65 2009 732 741
36. K.G. Kahl, N. Kruse, H. Faller, H. Weiß, and P. Rieckmann Expression of tumor necrosis factor-α and interferon-γ mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis Psychoneuroendocrinology 27 2002 671 681
37. D.C. Mohr, D.E. Goodkin, J. Islar, S.L. Hauser, and C.P. Genain Treatment of depression is associated with suppression of nonspecific and antigen-specific th1 responses in multiple sclerosis Arch Neurol 58 2001 1081 1086
38. M. Maes, and F.N. Twisk Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways BMC Med 8 2010 35 47
39. M. Maes, I. Mihaylova, M. Kubera, J.C. Leunis, and M. Geffard IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: new pathways that underpin the inflammatory and neuroprogressive pathophysiology J Affect Disord 135 2011 414 418
40. C.M. Geffard, D. Bodet, Y. Martinet, and M.-P. Dabadie Detection of the specific IgM and IgA circulating in sera of multiple sclerosis patients: interest and perspectives Immuno-analyse Biologie Spécialisée 17 2002 302 310
41. S. Pittion-Vouyovitch, M. Debouverie, F. Guillemin, N. Vandenberghe, R. Anxionnat, and H. Vespignani Fatigue in multiple sclerosis is related to disability, depression and quality of life J Neurol Sci 243 2006 39 45
42. I.K. Penner, N. Bechtel, C. Raselli, M. Stöcklin, K. Opwis, and L. Kappos Fatigue in multiple sclerosis: relation to depression, physical impairment, personality and action control Mult Scler 13 2007 1161 1167
43. E. Patrick, C. Christodoulou, L.B. Krupp, and on behalf of the New York State MS Consortium Longitudinal correlates of fatigue in multiple sclerosis Mult Scler 15 2009 258 261
44. L.B. Strober, and P.A. Arnett An examination of four models predicting fatigue in multiple sclerosis Arch Clin Neuropsychol 20 2005 631 646